AA
ARNA

AlphaCentric Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

AlphaCentric Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.53M Hold
16,500
– – 0.45% 11
2021
Q3 		$983K Buy
16,500
+9,000
+120% +$532K 0.25% 31
2021
Q2 		$512K Buy
7,500
+4,750
+173% +$310K 0.14% 60
2021
Q1 		$191K Hold
2,750
– – 0.06% 96
2020
Q4 		$211K Buy
+2,750
New +$206K 0.09% 64

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AlphaCentric Advisors's ARNA Position: Q4 2021 in Review

AlphaCentric Advisors held its Arena Pharmaceuticals Inc (ARNA) position steady in Q4 2021 at 16,500 shares worth $1.53M. The position accounts for 0.45% of the portfolio, ranked #11.

AlphaCentric Advisors first reported a position in ARNA in Q4 2020 and has held it in 5 quarters since. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • AlphaCentric Advisors held 16,500 shares of Arena Pharmaceuticals Inc worth $1.53M as of Q4 2021.
  • AlphaCentric Advisors left its Arena Pharmaceuticals Inc share count unchanged in Q4 2021.
  • Arena Pharmaceuticals Inc made up 0.45% of AlphaCentric Advisors's portfolio in Q4 2021, its #11 holding.
  • AlphaCentric Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and has held it in 5 quarters since.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.